Privia Health Group (NASDAQ:PRVA) & 111 (NASDAQ:YI) Head-To-Head Review

111 (NASDAQ:YI) and Privia Health Group (NASDAQ:PRVA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Risk & Volatility

111 has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500.

Profitability

This table compares 111 and Privia Health Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
111	-0.52%	N/A	-2.72%
Privia Health Group	0.89%	2.52%	1.47%

Analyst Recommendations

This is a breakdown of recent ratings and target prices for 111 and Privia Health Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
111	1	0	0	0	1.00
Privia Health Group	0	3	13	0	2.81

Privia Health Group has a consensus target price of $30.00, suggesting a potential upside of 25.10%. Given Privia Health Group’s stronger consensus rating and higher probable upside, analysts clearly believe Privia Health Group is more favorable than 111.

Valuation and Earnings

This table compares 111 and Privia Health Group”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
111	$14.18 billion	0.00	-$1.42 million	($0.84)	-3.98
Privia Health Group	$1.74 billion	1.70	$14.39 million	$0.13	184.46

Privia Health Group has lower revenue, but higher earnings than 111. 111 is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

21.3% of 111 shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 43.9% of 111 shares are held by insiders. Comparatively, 10.7% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Privia Health Group beats 111 on 12 of the 14 factors compared between the two stocks.

About 111

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

About Privia Health Group

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.